top of page
Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
OVC1501
Ovary cancer tissue array, set 1, non-overlapping with OVC1502, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$307
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
I | |
J | |
TNM Classification: Ovary carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evidence of primary tumor
T1 - Tumor limited to the ovaries
T1a - Tumor limited to one ovary; capsule intact, no tumor invasion on ovarian surface; no malignant cells in ascites or peritoneal washings
T1b - Tumor limited to both ovaries; capsule intact, no tumor invasion on ovarian surface; no malignant cells in ascites or peritoneal washings
T1c - Tumor limited to one or both ovaries with any or the following features; capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washing
T2 - Tumor involves one or both ovaries with pelvic extension
T2a - Extension and/or implants on uterus and/or tube(s); no malignant cells in ascites or peritoneal washings
T2b - Extension to other pelvic tissue; no malignant cells in ascites or peritoneal washings
T2c - Pelvic extension (T2a or T2b) with malignant cells in ascites or peritoneal washings
T3 and/or N1 - Tumor involves both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis
T3a - Microscopic peritoneal metastasis beyond pelvis
T3b - Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension
T3c and/or N1 - Peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension and/or regional lymph node metastasis
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed
NO - No regional lymph node metastasis
N1 - Regional lymph node metastasis
M - Distant metastasis
MX - Distant metastasis cannot be assessed
MO - No distant metastasis
M1 - Distant metastasis (exclude peritoneal metastasis)
Human
75
150
1.1mm
4um
10
15
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in ovary cancers.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | F | 40 | Ovary | Normal | |||
A02 | F | 40 | Ovary | Normal | |||
A03 | F | 19 | Ovary | Mucinous cystadenoma | |||
A04 | F | 35 | Ovary | Thecoma | |||
A05 | F | 42 | Ovary | Borderline serous cystadenoma | |||
A06 | F | 53 | Ovary | Serous cystadenocarcinoma | III | T3N0M1 | |
A07 | F | 56 | Ovary | Serous cystadenocarcinoma | II~III | T3N0M1 | |
A08 | F | 40 | Ovary | Metastatic colon signet ring cell carcinoma | |||
A09 | F | 58 | Ovary | Serous cystadenocarcinoma | II~III | T3N0M1 | |
A10 | F | 50 | Ovary | Endometrioid adenocarcinoma | II~III | T3N0M1 | |
A11 | F | 65 | Ovary | Serous cystadenocarcinoma | I | T1N0M0 | |
A12 | F | 42 | Ovary | Endometrioid adenocarcinoma | III | T2N0M0 | |
A13 | F | 29 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
A14 | F | 51 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
A15 | F | 20 | Ovary | Serous cystadenocarcinoma | I~II | T1N0M0 | |
B01 | F | 40 | Ovary | Normal | |||
B02 | F | 40 | Ovary | Normal | |||
B03 | F | 19 | Ovary | Mucinous cystadenoma | |||
B04 | F | 35 | Ovary | Thecoma | |||
B05 | F | 42 | Ovary | Borderline serous cystadenoma | |||
B06 | F | 53 | Ovary | Serous cystadenocarcinoma | III | T3N0M1 | |
B07 | F | 56 | Ovary | Serous cystadenocarcinoma | II~III | T3N0M1 | |
B08 | F | 40 | Ovary | Metastatic colon signet ring cell carcinoma | |||
B09 | F | 58 | Ovary | Serous cystadenocarcinoma | II~III | T3N0M1 | |
B10 | F | 50 | Ovary | Endometrioid adenocarcinoma | II~III | T3N0M1 | |
B11 | F | 65 | Ovary | Serous cystadenocarcinoma | I | T1N0M0 | |
B12 | F | 42 | Ovary | Endometrioid adenocarcinoma | III | T2N0M0 | |
B13 | F | 29 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
B14 | F | 51 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
B15 | F | 20 | Ovary | Serous cystadenocarcinoma | I~II | T1N0M0 | |
C01 | F | 47 | Ovary | Serous cystadenocarcinoma | III | T1N0M0 | |
C02 | F | 53 | Ovary | Serous cystadenocarcinoma | III | T2N0M0 | |
C03 | F | 48 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
C04 | F | 44 | Ovary | Endometrioid adenocarcinoma | II~III | T1N0M0 | |
C05 | F | 51 | Ovary | Serous cystadenocarcinoma | III | T3N1M1 | |
C06 | F | 65 | Ovary | Endometrioid adenocarcinoma | II~III | T1N0M0 | |
C07 | F | 43 | Ovary | Serous cystadenocarcinoma | III | T1N0M0 | |
C08 | F | 45 | Ovary | Serous cystadenocarcinoma | II | T3N1M0 | |
C09 | F | 82 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
C10 | F | 47 | Ovary | Mucinous cystadenocarcinoma | I | T3N1M0 | |
C11 | F | 43 | Ovary | Mucinous cystadenocarcinoma | III | T2N0M0 | |
C12 | F | 63 | Ovary | Endometrioid adenocarcinoma | III | T2N0M0 | |
C13 | F | 54 | Ovary | Endometrioid adenocarcinoma | III | T2N0M0 | |
C14 | F | 56 | Ovary | Serous cystadenocarcinoma | I | T1N0M0 | |
C15 | F | 34 | Ovary | Serous cystadenocarcinoma | I | T2N0M0 | |
D01 | F | 47 | Ovary | Serous cystadenocarcinoma | III | T1N0M0 | |
D02 | F | 53 | Ovary | Serous cystadenocarcinoma | III | T2N0M0 | |
D03 | F | 48 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
D04 | F | 44 | Ovary | Endometrioid adenocarcinoma | II~III | T1N0M0 | |
D05 | F | 51 | Ovary | Serous cystadenocarcinoma | III | T3N1M1 | |
D06 | F | 65 | Ovary | Endometrioid adenocarcinoma | II~III | T1N0M0 | |
D07 | F | 43 | Ovary | Serous cystadenocarcinoma | III | T1N0M0 | |
D08 | F | 45 | Ovary | Serous cystadenocarcinoma | II | T3N1M0 | |
D09 | F | 82 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
D10 | F | 47 | Ovary | Mucinous cystadenocarcinoma | I | T3N1M0 | |
D11 | F | 43 | Ovary | Mucinous cystadenocarcinoma | III | T2N0M0 | |
D12 | F | 63 | Ovary | Endometrioid adenocarcinoma | III | T2N0M0 | |
D13 | F | 54 | Ovary | Endometrioid adenocarcinoma | III | T2N0M0 | |
D14 | F | 56 | Ovary | Serous cystadenocarcinoma | I | T1N0M0 | |
D15 | F | 34 | Ovary | Serous cystadenocarcinoma | I | T2N0M0 | |
E01 | F | 24 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
E02 | F | 58 | Ovary | Endometrioid adenocarcinoma | III | T2N0M0 | |
E03 | F | 25 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
E04 | F | 51 | Ovary | Endometrioid adenocarcinoma | I | T1N0M0 | |
E05 | F | 25 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
E06 | F | 50 | Ovary | Endometrioid adenocarcinoma | I | T3N1M1 | |
E07 | F | 40 | Ovary | Endodermal sinus tumor | T1N0M0 | ||
E08 | F | 34 | Ovary | Endodermal sinus tumor | T3N0M1 | ||
E09 | F | 33 | Ovary | Serous cystadenocarcinoma | I | T1N0M0 | |
E10 | F | 52 | Ovary | Endometrioid adenocarcinoma | III | T3N0M0 | |
E11 | F | 42 | Ovary | Endometrioid adenocarcinoma | I | T3N0M1 | |
E12 | F | 68 | Ovary | Endometrioid adenocarcinoma | III | T3N1M0 | |
E13 | F | 17 | Ovary | Endometrioid adenocarcinoma | I | T1N0M0 | |
E14 | F | 38 | Ovary | Mucinous cystadenocarcinoma | I | T1N1M0 | |
E15 | F | 48 | Ovary | Mucinous cystadenocarcinoma | III | T1N0M0 | |
F01 | F | 24 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
F02 | F | 58 | Ovary | Endometrioid adenocarcinoma | III | T2N0M0 | |
F03 | F | 25 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
F04 | F | 51 | Ovary | Endometrioid adenocarcinoma | I | T1N0M0 | |
F05 | F | 25 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
F06 | F | 50 | Ovary | Endometrioid adenocarcinoma | I | T3N1M1 | |
F07 | F | 40 | Ovary | Endodermal sinus tumor | T1N0M0 | ||
F08 | F | 34 | Ovary | Endodermal sinus tumor | T3N0M1 | ||
F09 | F | 33 | Ovary | Serous cystadenocarcinoma | I | T1N0M0 | |
F10 | F | 52 | Ovary | Endometrioid adenocarcinoma | III | T3N0M0 | |
F11 | F | 42 | Ovary | Endometrioid adenocarcinoma | I | T3N0M1 | |
F12 | F | 68 | Ovary | Endometrioid adenocarcinoma | III | T3N1M0 | |
F13 | F | 17 | Ovary | Endometrioid adenocarcinoma | I | T1N0M0 | |
F14 | F | 38 | Ovary | Mucinous cystadenocarcinoma | I | T1N1M0 | |
F15 | F | 48 | Ovary | Mucinous cystadenocarcinoma | III | T1N0M0 | |
G01 | F | 18 | Ovary | Serous cystadenocarcinoma | II | T1N0M0 | |
G02 | F | 36 | Ovary | Leimyosarcoma? | T1N0M0 | ||
G03 | F | 42 | Ovary | Serous cystadenocarcinoma | II~III | T2N0M0 | |
G04 | F | 42 | Ovary | Serous cystadenocarcinoma | II~III | T3N0M1 | |
G05 | F | 23 | Ovary | Endodermal sinus tumor | |||
G06 | F | 45 | Ovary | Serous cystadenocarcinoma | III | T2N0M0 | |
G07 | F | 18 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
G08 | F | 48 | Ovary | Serous cystadenocarcinoma | II | T1N0M0 | |
G09 | F | 49 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
G10 | F | 51 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
G11 | F | 48 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
G12 | F | 43 | Ovary | Granulosa cell tumor | |||
G13 | F | 51 | Ovary | Serous cystadenocarcinoma | III | T1N0M0 | |
G14 | F | 71 | Ovary | Endometrioid adenocarcinoma | III | T3N0M1 | |
G15 | F | 58 | Ovary | Endometrioid adenocarcinoma | III | T3N0M1 | |
H01 | F | 18 | Ovary | Serous cystadenocarcinoma | II | T1N0M0 | |
H02 | F | 36 | Ovary | Leimyosarcoma? | T1N0M0 | ||
H03 | F | 42 | Ovary | Serous cystadenocarcinoma | II~III | T2N0M0 | |
H04 | F | 42 | Ovary | Serous cystadenocarcinoma | II~III | T3N1M1 | |
H05 | F | 23 | Ovary | Endodermal sinus tumor | |||
H06 | F | 45 | Ovary | Serous cystadenocarcinoma | III | T2N0M0 | |
H07 | F | 18 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
H08 | F | 48 | Ovary | Serous cystadenocarcinoma | II | T1N0M0 | |
H09 | F | 49 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
H10 | F | 51 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
H11 | F | 48 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
H12 | F | 43 | Ovary | Granulosa cell tumor | T1N0M0 | ||
H13 | F | 51 | Ovary | Serous cystadenocarcinoma | III | T1N0M0 | |
H14 | F | 71 | Ovary | Endometrioid adenocarcinoma | III | T3N0M1 | |
H15 | F | 58 | Ovary | Endometrioid adenocarcinoma | III | T3N0M1 | |
I01 | F | 17 | Ovary | Dysgerminoma | |||
I02 | F | 50 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
I03 | F | 44 | Ovary | Serous cystadenocarcinoma | III | T2N0M0 | |
I04 | F | 54 | Ovary | Serous cystadenocarcinoma | II~III | T3N1M1 | |
I05 | F | 39 | Ovary | Mucinous cystadenocarcinoma | I | T3N0M1 | |
I06 | F | 39 | Ovary | Endometrioid adenocarcinoma | III | T2N0M0 | |
I07 | F | 53 | Ovary | Mucinous cystadenocarcinoma | II | T1N0M0 | |
I08 | F | 43 | Ovary | Endometrioid adenocarcinoma | I | T1N0M0 | |
I09 | F | 74 | Ovary | Serous cystadenocarcinoma | III | T1N0M0 | |
I10 | F | 52 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
I11 | F | 56 | Ovary | Serous cystadenocarcinoma | III | T3N0M1 | |
I12 | F | 54 | Ovary | Endometrioid adenocarcinoma | III | T3N0M1 | |
I13 | F | 54 | Ovary | Serous cystadenocarcinoma | III | T3N0M1 | |
I14 | F | 23 | Ovary | Mucinous cystadenocarcinoma | I~II | T1N0M0 | |
I15 | F | 52 | Ovary | Clear cell carcinoma | II | T1N0M0 | |
J01 | F | 17 | Ovary | Dysgerminoma | |||
J02 | F | 50 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
J03 | F | 44 | Ovary | Serous cystadenocarcinoma | III | T2N0M0 | |
J04 | F | 54 | Ovary | Serous cystadenocarcinoma | II~III | T3N1M1 | |
J05 | F | 39 | Ovary | Mucinous cystadenocarcinoma | I | T3N0M1 | |
J06 | F | 39 | Ovary | Endometrioid adenocarcinoma | III | T2N0M0 | |
J07 | F | 53 | Ovary | Mucinous cystadenocarcinoma | II | T1N0M0 | |
J08 | F | 43 | Ovary | Endometrioid adenocarcinoma | I | T1N0M0 | |
J09 | F | 74 | Ovary | Serous cystadenocarcinoma | III | T1N0M0 | |
J10 | F | 52 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
J11 | F | 56 | Ovary | Serous cystadenocarcinoma | III | T3N0M1 | |
J12 | F | 54 | Ovary | Endometrioid adenocarcinoma | III | T3N0M1 | |
J13 | F | 54 | Ovary | Serous cystadenocarcinoma | III | T3N0M1 | |
J14 | F | 23 | Ovary | Mucinous cystadenocarcinoma | I~II | T1N0M0 | |
J15 | F | 52 | Ovary | Clear cell carcinoma | II | T1N0M0 | |
null |
bottom of page